861 results on '"Lim, Joseph K."'
Search Results
102. Su1576 CANNABIS USE DISORDER IS ASSOCIATED WITH INCREASED RISK OF ACUTE MYOCARDIAL INFARCTION IN US ADULTS WITH MASH CIRRHOSIS: A POPULATION-BASED ANALYSIS
103. Sa1621 UNIVERSAL TESTING FOR HEPATITIS DELTA VIRUS (HDV) AMONG PATIENTS WITH CHRONIC HEPATITIS B DEMONSTRATES LOW PREVALENCE OF HDV INFECTION
104. Introduction of Clinical Practice Update Committee Articles
105. The independent effect of exercise on biopsyproven non-alcoholic fatty liver disease: A systematic review.
106. Diagnosis, Management, and Prevention of Hepatitis B Reactivation
107. Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
108. NASH and the Gut Microbiome: Implications for New Therapies
109. Oral Cyanobacteria and Hepatocellular Carcinoma
110. Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome‐wide association study
111. Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis
112. HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape
113. Care of the Patient With Abnormal Liver Test Results
114. AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update
115. The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
116. Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study
117. Emerging trends in hepatocellular carcinoma incidence and mortality
118. LEFT ATRIAL STRAIN AND DIASTOLIC DYSFUNCTION AMONGST HIV-POSITIVE INDIVIDUALS: INSIGHTS FROM THE VETERANS AGING COHORT STUDY
119. Willingness to participate in research among black patients with liver disease: A national cross‐sectional study
120. The Role of Hepatic Steatosis in Chronic Hepatitis B Infection
121. Histologic Disease in Patients with Chronic Hepatitis B, High HBV DNA, and Normal Alanine Aminotransferase Levels
122. Advances in interferon-free hepatitis C therapy: 2014 and beyond
123. Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients: A Cohort Study
124. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
125. Patient‐reported outcomes 12 months after hepatitis C treatment with direct‐acting antivirals: Results from the PROP UP study
126. The HCV Treatment Cascade by Prior Incarceration Status in Veterans With and Without HIV
127. Hepatocellular Cancer in the Absence of Viral Hepatitis: Implications for Prevention
128. Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
129. Mo1545 EVALUATING HEPATITIS DELTA VIRUS DISEASE PREVALENCE AND PATIENT CHARACTERISTICS AMONG ADULTS IN THE UNITED STATES: AN ANALYSIS OF ALL-PAYER CLAIMS DATABASE
130. Sa1548 AN EXPLAINABLE ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HIGH-RISK NONALCOHOLIC STEATOHEPATITIS
131. 554 RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA ACROSS A GRADIENT OF BASELINE HEPATITIS B VIRAL LOAD AMONG A NATIONAL COHORT OF PREDOMINANTLY NON-ASIAN VETERANS WITH CHRONIC HEPATITIS B IN THE UNITED STATES
132. Sa1523 ON-TREATMENT RISK OF HEPATOCELLULAR CARCINOMA DOES NOT DIFFER BY BASELINE HEPATITIS B VIRAL LOAD AMONG A LARGE COHORT OF PREDOMINANTLY NON-ASIAN PATIENTS WITH NON-CIRRHOTIC E ANTIGEN NEGATIVE CHRONIC HEPATITIS B
133. Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy
134. Waking Up the Sleeping Giant: Treatment of Hepatitis B Reactivation During Immunosuppressive Drug Therapy
135. AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
136. Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints
137. Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
138. Abnormal Liver Tests in COVID‐19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network
139. Impact of Rapid Point-Of-Care Screening Tests for the Identification of Chronic Hepatitis C Infection
140. Association of AKI With Mortality and Complications in Hospitalized Patients With Cirrhosis
141. Cost-Effectiveness of Universal Hepatitis B Vaccination in U.S. Adults with Diabetes Mellitus: A Markov Simulation Model: 343
142. Antibiotic Prophylaxis and Management of Bacterial Infections
143. Residents' prescription writing for nonpatients. (On Call: Issues in Graduate Medical Education)
144. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GS-9450 in Subjects With Nonalcoholic Steatohepatitis
145. Impact of Insulin-Sensitizing Agents on Risk for Liver Cancer and Liver-Related Death in Diabetic Patients with Compensated Hepatitis C Cirrhosis
146. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study
147. Degeneration of structural brain networks is associated with cognitive decline after ischaemic stroke
148. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort
149. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic
150. Budd-Chiari Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.